BioCopy AG
- Biotech or pharma, therapeutic R&D
BioCopy specializes in the development of multispecific T-cell engagers against pHLA targets of solid tumors using its proprietary AI-based ultra-high-throughput technology to rapidly deliver the safest possible therapeutics to patients.